Treating Glaucoma | glaucoma.org

文章推薦指數: 80 %
投票人數:10人

Selective laser ... DonateNow Search Genericfilters FilterbyCategories Hiddenlabel EyeHealth Hiddenlabel PersonalStories Hiddenlabel Facts&Stats Hiddenlabel LifestyleTips Hiddenlabel EyeExams Hiddenlabel Treatments Hiddenlabel Q&A Hiddenlabel ResearchUpdates Hiddenlabel News LearnaboutGlaucoma WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources VideosandWebinars Research CatalystforaCure ShafferResearchGrants ApplyforaGrant PublicationsandAbstracts VideosandWebinars GetInvolved WaystoGive FundraiseforGRF Volunteer PlannedGiving Events Glaucoma360 AnnualGala NewHorizonsForum PatientSummit Webinars GRFBlog News ResearchUpdates PersonalStories EnEspañol More… AboutUs Mission&History People GRFAmbassadors Financials Menu LearnaboutGlaucoma WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources VideosandWebinars Research CatalystforaCure ShafferResearchGrants ApplyforaGrant PublicationsandAbstracts VideosandWebinars GetInvolved WaystoGive FundraiseforGRF Volunteer PlannedGiving Events Glaucoma360 AnnualGala NewHorizonsForum PatientSummit Webinars GRFBlog News ResearchUpdates PersonalStories EnEspañol More… AboutUs Mission&History People GRFAmbassadors Financials Donate Search Genericfilters FilterbyCategories Hiddenlabel EyeHealth Hiddenlabel PersonalStories Hiddenlabel Facts&Stats Hiddenlabel LifestyleTips Hiddenlabel EyeExams Hiddenlabel Treatments Hiddenlabel Q&A Hiddenlabel ResearchUpdates Hiddenlabel News Donate LearnaboutGlaucoma WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources VideosandWebinars Research CatalystforaCure ShafferResearchGrants ApplyforaGrant PublicationsandAbstracts VideosandWebinars GetInvolved WaystoGive FundraiseforGRF Volunteer PlannedGiving Events Glaucoma360 AnnualGala NewHorizonsForum PatientSummit Webinars GRFBlog News ResearchUpdates PersonalStories EnEspañol More… AboutUs Mission&History People GRFAmbassadors Financials Menu LearnaboutGlaucoma WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources VideosandWebinars Research CatalystforaCure ShafferResearchGrants ApplyforaGrant PublicationsandAbstracts VideosandWebinars GetInvolved WaystoGive FundraiseforGRF Volunteer PlannedGiving Events Glaucoma360 AnnualGala NewHorizonsForum PatientSummit Webinars GRFBlog News ResearchUpdates PersonalStories EnEspañol More… AboutUs Mission&History People GRFAmbassadors Financials TreatingGlaucoma >>enEspañol<< WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources Videos Menu WhatisGlaucoma? TypesofGlaucoma TestingforGlaucoma TreatingGlaucoma PatientResources Videos Glaucomaistreatedbyloweringintraocularpressure,andthiscanbeachievedwithlasersurgery,medications,conventional(“incisional”)surgery,oracombinationofthese.Treatmentplanscandifferdependingonthetypeofglaucomaandtheindividualpatient.Treatmentoptionsareorganizedbelowbyglaucomatype. TreatmentofPrimaryOpen-AngleGlaucoma SELECTIVELASERTRABECULOPLASTY(SLT)Selectivelasertrabeculoplasty(SLT),oftenafirst-linetreatmentforOpen-AngleGlaucoma,canalsobeeffectiveinpatientsalreadyoneyedrops.SLTuseslowlevelsoflaserlighttoimprovedrainageofintraocularfluidthroughthenaturaldrainagepathwayoutoftheeye.Formosteyesthisimproveddrainagehelpslowereyepressureandasingletreatment’seffectlasts2to3years,andsometimeslonger.SinceSLTleavesthedrainagecanalsintact,itcanberepeatediftheinitialtreatmentwaseffective.Minorself-limitedinflammationfollowsSLTandmayaidintheeyepressureloweringeffect.SomepatientscanhavetheireyepressurecontrolledwithSLTalone.Othersrequireglaucomamedicationsalsoorincisionalsurgeryintheoperatingroom.Whattoexpect:• SLTisperformedinanoutpatientsetting,frequentlyinthedoctor’soffice.• Yourdoctorwillusespecialeyedropstonumbyoureye.Then,yourdoctorwillhaveyousitatthelaserandplaceaspeciallenswithcontactlensgelonyoureyetohelpdirectthelaserlightontothedrainagecanalsinyoureye.• Youwillhearaseriesofclicksandseebrightlights,likeacameraflash,asyourdoctorperformstheprocedure.Youmayfeelaslighttinglingsensation,buttheprocedureisnearlypainless.• SLTtakesabout5-10minutes.• Attheendofthetreatment,thelensisremovedandyourvisionwillbeblurryuntilthethickcontactlensgelisrinsedoff.• Afterthetreatment,youshouldtakeiteasyforadayandthenreturntoyourdailyroutine.GLAUCOMAMEDICATIONSOpen-AngleGlaucomaisoftentreatedwithmedicationsthateitherhelptheeye’sfluiddrainbetterordecreasetheamountoffluidbeingmade.Medicationsmustbetakendailytokeepeyepressureatasafelevel.Inmostcases,medicationscansafelycontroleyepressureformanyyears.Itisnormalforyourmedicationprescriptionstochangeovertime.Changingmedicationsdoesnotnecessarilymeanthatyourglaucomaisgettingworse.Asyourbodybeginstodevelopatoleranceforamedication,itmayslowlyloseitseffectivenessandmayneedtobereplacedbyastrongerversionofthesamedrugoradifferentmedication.Doctorsoftencanreturntopreviouslyusedmedicationsafteryourbodyhashadachanceto“forget”theoldmedication.Glaucomamedicationsmostcommonlyareintheformofeyedrops.putdropsinyoureyecorrectly.Mostmedicationshavesomesideeffects,includingeffectsonvision,eyecomfort,andsometimesotherpartsofyourbody.Inparticular,olderpeoplewithglaucomashouldlookforchangesinbehaviorormobilitythatmaybeasideeffectofmedications.Ifthesideeffectsareveryuncomfortableorlastawhile,yourdoctormaybeabletoprescribeadifferentmedication.Tomakesureyourglaucomamedicationsarenotinteractingwithothermedicationsyouaretaking,makesuretotellallofyourdoctors,includingyourfamilyphysician,aboutyourglaucomamedicationsandanyotherdrugsyoumaybetaking,includingaspirin,vitaminsandnaturalremedies.Tellyourdoctorsaboutanysideeffectsyoumaybeexperiencingorallergiesyouhave.Thefollowingaresomeofthepossiblesideeffectsofthemainclassesofglaucomamedications:•ProstaglandinAnalogsEyecolorchange,darkeningofeyelidskin,eyelashgrowth,droopyeyelids,sunkeneyes,stinging,eyeredness,anditching•BetaBlockersLowbloodpressure,slowedpulserate,fatigue,shortnessofbreath•AlphaAgonistsBurningorstinging,fatigue,headache,drowsiness,drymouthandnose,allergicreaction•CarbonicAnhydraseInhibitorsIneyedropform—stinging,burning,eyediscomfort;inpillform—tinglinghandsandfeet,fatigue,stomachupset,memoryproblems,frequenturination•RhoKinaseInhibitorsEyeredness,depositsoncornea,stinging,smallbleedsonthewhiteoftheeyeNewTreatmentsontheHorizonNewformsofglaucomadrugdeliveryarebeingdevelopedtoimprovemedicationtreatmentoptions.Oneareaofinterestis“sustained-release”medication.Sustained-releasemedicationevenlyreleasesadrugoveralongertime.Inthisway,medicationscanbeusedweekly,monthly,oratevenlongerintervals.Thiswouldmaketheprocessoftakingmedicationsmoreconvenientandefficientandpotentiallyreducesideeffects.Therearemanysustained-releaseoptionsbeingresearchedanddeveloped.Inaddition,newclassesofdrugstotreatglaucomaarebeingstudied.Researchersareworkingtofindglaucomamedicationswithfewersideeffects,onesthatcanbetakenlessoften,anddrugsthataremoreresponsivetotheeyeandsomoreeffectiveatloweringeyepressure.INCISIONALSURGERYWhenSLT,glaucomamedications,andothertreatmentsdonotlowereyepressuretothedesiredlevel,yourdoctormayrecommendsomeformofincisionalsurgery.Thissurgeryisdoneinahospitalorsurgerycenter,usingamicroscopeandmicrosurgeryinstruments,andincludesmakingacut(incision)intheeye.Whattoexpect:•Beforesurgerybegins,alocalanestheticalongwithamedicationtohelpyourelaxisgiventopreventyoufromfeelinganydiscomfortduringtheprocedure.•Duringsurgery,thedoctorlooksthroughamicroscopethatisplacedseveralinchesaboveyoureye.•Eyesurgerydoesrequiresomerecoverytime,whichwillvaryaccordingtoyourage,dailyactivities,andotherpersonalfactors.Mostpeoplecanmovearoundandreturntotheirnormalactivitiessoonaftergoinghome,thoughyoumayhavetowearaneyepatchtoprotectyoureye.•Foratleastaweekafterglaucomasurgery,itisadvisabletokeepwateroutoftheeye.Itisalsogoodtotakeabreakfromdriving,reading,bending,andstrenuousexercise.•Glaucomasurgerymayhavetoberepeated,especiallyifexcessivescarringcannotbepreventedorafterlongperiodsoftime.MinimallyInvasiveGlaucomaSurgery(MIGS)MinimallyInvasiveGlaucomaSurgery(MIGS)procedureshavebeendevelopedinrecentyearstotreatpatientsearlierandmoresafelythanconventionalsurgery.Aswithallnewprocedures,multi-yearfollow-upstudiesarerequiredtoseewhichoneswillremainusefullong-term.MIGSproceduresincludemicrosurgicalinstrumentsanddevicesandsmallerincisionsthatmanipulatetheeyetissueslessandthereforereducetheriskofcomplications.Theincreasedsafetyofthesesurgeriesistradedforreducedeffectiveness.MIGSproceduresanddevicesmayworkinanumberofways.Someenhancefluidoutflowwithintheeye’sdrainagesystem,somecarryfluidtotheoutsideoftheeye.SometypesofMIGSproceduresaretobedoneonlywithcataractsurgery,whereasotherMIGSprocedurescanbeperformedindependentofcataractsurgery.Cataractsurgeryalonelowerspressure,andthecombinationofaMIGSsurgeryandcataractsurgerycanlowerpressuremoretohelpreducetheneedformedication.ImplantingaMIGSdeviceaddsafewminutestocataractsurgery.TheMIGSgroupofdevicesandsurgeriesaredividedintocategoriesaccordingtohowtheywork:•Miniaturizedversionsoftrabeculectomy:Intheseprocedures,tinytubesareinsertedintotheeyetohelpdrainfluidfrominsidetheeyetounderneaththeoutermembraneoftheeye(conjunctiva).Forexample,theFDAclearedXENGelStentandthePRESERFLO(formerlyInnFocus)MicroShuntclearedoutsidetheUS.•Trabecularsurgery:Severalproceduresusespecializedinstrumentsanddevicestocutthroughorbypasstheeye’sdrainagecanals(trabecularmeshwork)withoutdamaginganyothertissuesinthedrainagepathway.TheTrabectome,Trab360,andKahookDualBladeproceduresareexamplesofthistypeofsurgery.•Totallyinternalshunts:Usingtinytubeswithverysmallinternalopenings,thefrontoftheeyeisconnectedtothedrainagechannelsoftheeyebypassingthetrabecularmeshworktoimprovethedrainageoffluidfromtheeye.ShuntsmadebyGlaukosandIvantisaredevicescurrentlyinuse. Conventionalsurgeriesforglaucomaincludetrabeculectomyoraqueousshunts(seebelow).Whiletheycanbemoreeffectiveatloweringeyepressureandpreventingprogressionofglaucoma,theyalsohavemorepotentialcomplications.TrabeculectomySurgeryInthisprocedure,atinyopeningismadeinthesclera(thewhitepartoftheeye)withasmallsurgicalinstrument.Thisnewopeningallowstheintraocularfluidtobypassthecloggeddrainagecanalsanddirectlyflowoutofthisnewopening.Specialmedications(“antifibrotics”)maybeusedtopreventscarringandclosureofthenewopening.Theopeningiscoveredbyconjunctivacreatingablebonthesclera.Thisprocedurerequiresstitchesandtherecoveryperiodisusuallyafewweeks.AqueousShuntSurgeryDuringaqueousshuntsurgery,atinytubeisimplantedthatdrainsfluidoutoftheeye.Liketrabeculectomy,thisconventionalsurgeryalsorequiresstitchesandtherecoveryperiodisusuallyafewweeks.UNAPPROVEDTREATMENTSTherearemanyunapprovedtreatmentsthatarepromotedontheinternetandelsewhere,includingmarijuana/cannabidiol(CBD),stemcells,herbalmedicines,andnutritionalsupplements.Thesetreatmentsarenotpartofthestandardofcareinglaucomatreatmentandmaynegativelyimpactyourcurrenttreatment.Youshoulddiscussanyadditionaltreatmentsyouareconsideringwithyourdoctorbeforestartingthem. TreatmentofPrimaryAngle-ClosureGlaucoma TreatmentofAngle-ClosureGlaucomaandeyesatriskforthisdiseaseusuallyinvolvesalaserprocedure,laserperipheraliridotomy,tocreateasmallopeningintheouteredgeoftheiris.IfyouhaveAngle-ClosureGlaucomainoneeye,yourdoctormaytreattheothereyeasasafetymeasure.OthertreatmentsaresimilartothoseforOpen-AngleGlaucomaandincludemedicationstolowereyepressure,trabeculectomyortubeshuntsurgery,and,rarely,SelectiveLaserTrabeculoplasty.Tolearnmoreaboutthesetreatments,seethecorrespondingsectionsforOpen-AngleGlaucomaintheTreatingGlaucomasection(above).CataractsurgeryhasalsobeenshowntohelpinthetreatmentofPrimaryAngle-ClosureGlaucoma.Removingthecataractopenstheangleandusuallyhasafavorableeffectontheeyepressure. TreatmentofOtherTypesofGlaucoma TreatmentofNormal-TensionGlaucomaMostdoctorstreatNormal-TensionGlaucomabyreducingtheeyepressureaslowaspossibleusingmedications,lasertreatments,andsurgery.TreatmentofPigmentaryGlaucomaThetreatmentofPigmentaryGlaucomainvolvesloweringeyepressureusingmedications,lasertreatments,orsurgery.Unfortunately,itisdifficulttoreduceoreliminatethereleaseofirispigment.Therefore,attentionisfocusedonreducingeyepressure.TreatmentofCongenitalGlaucomaBothmedicationandsurgeryareusedtotreatCongenitalGlaucoma.Medicationscanbeintheformofeyedrops,pills,orliquidstobetakenbymouth.Lasersurgeryalsomaybeused.Thesetreatmentshelptoeitherdecreasetheamountoffluidmadeintheeyeorincreasetheamountoffluidoutoftheeyetolowereyepressure.SurgicalproceduresthatareusedtohelpcontroleyepressureinCongenitalGlaucomaincludefilteringsurgery,aqueousshuntsurgery,andgoniosurgery,aspecialprocedurethatopenscanalsinthetrabecularmeshwork.Itissometimesnecessarytorepeatglaucomasurgeryinordertosuccessfullycontroleyepressure. TreatmentofExfoliativeGlaucomaGenerally,thiskindofglaucomaismoredifficulttocontrolwithmedication.PatientswithExfoliativeGlaucomaoftenrequireamoreaggressive,stepwisetreatmentplanandmoreoftenneedlasertreatmentorsurgery.Oftenmorefrequentvisitstotheireyedoctorarenecessarytomonitorfordiseaseprogression.TreatmentofNeovascularGlaucomaTreatmentsforNeovascularGlaucomaofteninvolvedecreasingthegrowthofbloodvessels.Thesetreatmentsincludelasertreatmenttotheretinaandanti-VEGFdrugswhichleadtoregressionofabnormalbloodvesselsintheeye.MedicationsusedforOpen-AngleGlaucomamaybeusedalso,aswellassurgerythatincludestrabeculectomyanddrainageimplantprocedures.TreatmentofUveiticGlaucomaTotreatelevatedeyepressureinUveiticGlaucoma,doctorsusemanyofthesameeyepressure-loweringmedicationsasthoseusedforOpen-AngleGlaucoma.Lasertreatmentstypicallyarenotusedbecausetheycancausemoreinflammation.Incasesthatcannotbecontrolledwithmedication,surgicaltreatmentmayinvolveanaqueousshunt.Inadditiontotreatmentbyaneyedoctor,sometimesarheumatologistwillprescribemedicationtotreattherootcauseoftheinflammation.TreatmentofTraumaticGlaucomaThetreatmentofTraumaticGlaucomavariesdependingonwhenglaucomadevelopsandthetypeofeyeinjury.Whenglaucomaoccursyearsafteraneyeinjury,thetreatmentissimilartoOpen-AngleGlaucomaexceptthatSLTisusuallynoteffective.Whenglaucomadevelopsimmediatelyaftereyeinjury,thetreatmentismainlyguidedbythetypeoftraumaandtheextentofdamagetotheeye. RelatedVideos LASERIRIDOTOMYSELECTIVELASERTRABECULOPLASTY(SLT)CATARACTSINFORMATIONDRYEYETREATMENTOCULARHYPERTENSION Topofpage LearnMore DryEyesandGlaucoma:DoubleTroubles DryEyeSyndromeandglaucomacommonlyoccurtogether. ReadMore>> WhatYouCanDotoManageYourGlaucoma Herearesometipstohelpyoustayontrackwithyourmedicationroutine. ReadMore>> WhenYouHaveCataractsandGlaucoma Patientswithbothcataractsandglaucomarequirespecialconsideration. ReadMore>> EyeDropTips Prescriptioneyedropsforglaucomahelpmaintainthepressureinyoureyeatahealthylevel. ReadMore>> Helpuscureglaucoma.Donatetoday! MoreAboutGRF OurGoals OurMission ConnectingwithOurCommunity CollaborativeResearch LeadershipTeam GRFAmbassadors HowcanWeHelp? ApplyforaGrant OrderOurBookletforPatients MakeaDifference ResourcesforPatients CelebrateOurSuccesseswithUs StayInformed AnEventJustforPatients ReadPersonalStories SiteInformation Accessibility PrivacyPolicy TermsandConditions Sitemap ContactUs InformacionenEspañol StayinTouch Facebook Twitter Vimeo YouTube LinkedIn Instagram Pinterest SubscribetoGleamsNewsletter TheGleamsNewsletterincludesinterviews,personalstories,andcurrentinformationaboutglaucoma,newtreatments,updatesonresearchfindings,andmore.YoucansubscribetotheprintedversionofGleamsortheelectronicversion—botharefree. printsubscription E-mailsubscription SubscribetoGleamsNewsletter TheGleamsNewsletterincludesinterviews,personalstories,andcurrentinformationaboutglaucoma,newtreatments,updatesonresearchfindings,andmore.YoucansubscribetotheprintedversionofGleamsortheelectronicversion—botharefree. printsubscription E-mailsubscription FOREYECAREPROFESSIONALS Orderourpatientinformationbookletsinbulk AttendourGlaucoma360events LearnabouttheGRFAmbassadors Orderourpatientinformationbookletsinbulk AttendourGlaucoma360events LearnabouttheGRFAmbassadors FOREYECAREPROFESSIONALS GlaucomaResearchFoundation • 251PostStreet,Suite600 • SanFrancisco,CA94108 • 415-986-3162 SendusanemailWearea501c3tax-exemptnationalnonprofit.OurtaxIDnumberis94-2495035.OurEINnumberis94-2495035.Copyright2022allrightsreserved. PrintSubscription (TheprintededitionoftheGleamsnewsletterisonlyavailableifyouliveintheUnitedStatesorCanada) Name(Required) First Last Address(Required) StreetAddress City StateorProvince ZIP/PostalCode CountryAfghanistanAlbaniaAlgeriaAmericanSamoaAndorraAngolaAnguillaAntarcticaAntiguaandBarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire,SintEustatiusandSabaBosniaandHerzegovinaBotswanaBouvetIslandBrazilBritishIndianOceanTerritoryBruneiDarussalamBulgariaBurkinaFasoBurundiCambodiaCameroonCanadaCapeVerdeCaymanIslandsCentralAfricanRepublicChadChileChinaChristmasIslandCocosIslandsColombiaComorosCongo,DemocraticRepublicoftheCongo,RepublicoftheCookIslandsCostaRicaCroatiaCubaCuraçaoCyprusCzechRepublicCôted'IvoireDenmarkDjiboutiDominicaDominicanRepublicEcuadorEgyptElSalvadorEquatorialGuineaEritreaEstoniaEswatini(Swaziland)EthiopiaFalklandIslandsFaroeIslandsFijiFinlandFranceFrenchGuianaFrenchPolynesiaFrenchSouthernTerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeardandMcDonaldIslandsHolySeeHondurasHongKongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsleofManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaoPeople'sDemocraticRepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshallIslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNewCaledoniaNewZealandNicaraguaNigerNigeriaNiueNorfolkIslandNorthKoreaNorthernMarianaIslandsNorwayOmanPakistanPalauPalestine,StateofPanamaPapuaNewGuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuertoRicoQatarRomaniaRussiaRwandaRéunionSaintBarthélemySaintHelenaSaintKittsandNevisSaintLuciaSaintMartinSaintPierreandMiquelonSaintVincentandtheGrenadinesSamoaSanMarinoSaoTomeandPrincipeSaudiArabiaSenegalSerbiaSeychellesSierraLeoneSingaporeSintMaartenSlovakiaSloveniaSolomonIslandsSomaliaSouthAfricaSouthGeorgiaSouthKoreaSouthSudanSpainSriLankaSudanSurinameSvalbardandJanMayenIslandsSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidadandTobagoTunisiaTurkeyTurkmenistanTurksandCaicosIslandsTuvaluUSMinorOutlyingIslandsUgandaUkraineUnitedArabEmiratesUnitedKingdomUnitedStatesUruguayUzbekistanVanuatuVenezuelaVietnamVirginIslands,BritishVirginIslands,U.S.WallisandFutunaWesternSaharaYemenZambiaZimbabweÅlandIslands Country Email(Required) NameThisfieldisforvalidationpurposesandshouldbeleftunchanged. Youcanunsubscribeatanytime.GRFwillnotshareyourpersonalinformationwithanyotherorganizations.PleaseseeourPrivacyPolicyforfurtherinformation. E-mailSubscription Email Name First Last CommentsThisfieldisforvalidationpurposesandshouldbeleftunchanged. Youcanunsubscribeatanytime.GRFwillnotshareyourpersonalinformationwithanyotherorganizations.PleaseseeourPrivacyPolicyforfurtherinformation.



請為這篇文章評分?